AI 28568/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1992	1
1993	2
1994	3
1996	2
1997	4
2000	1
2001	2
2002	1
2003	1
2004	1
2024	0

1

The rationale for immunotherapy in HIV-1 infection.

Walker BD. Walker BD. J Acquir Immune Defic Syndr (1988). 1994;7 Suppl 1:S6-13. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8182510 Review.

2

Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor.

Harrer E, Harrer T, Barbosa P, Feinberg M, Johnson RP, Buchbinder S, Walker BD. Harrer E, et al. J Infect Dis. 1996 Feb;173(2):476-9. doi: 10.1093/infdis/173.2.476. J Infect Dis. 1996. PMID: 8568316

3

Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.

Yu XG, Shang H, Addo MM, Eldridge RL, Phillips MN, Feeney ME, Strick D, Brander C, Goulder PJ, Rosenberg ES, Walker BD, Altfeld M; HIV Study Collaboration. Yu XG, et al. AIDS. 2002 Feb 15;16(3):321-8. doi: 10.1097/00002030-200202150-00002. AIDS. 2002. PMID: 11834942

4

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.

Schooley RT, Spino C, Kuritzkes D, Walker BD, Valentine FA, Hirsch MS, Cooney E, Friedland G, Kundu S, Merigan TC Jr, McElrath MJ, Collier A, Plaeger S, Mitsuyasu R, Kahn J, Haslett P, Uherova P, deGruttola V, Chiu S, Zhang B, Jones G, Bell D, Ketter N, Twadell T, Chernoff D, Rosandich M. Schooley RT, et al. J Infect Dis. 2000 Nov;182(5):1357-64. doi: 10.1086/315860. Epub 2000 Oct 9. J Infect Dis. 2000. PMID: 11023459 Clinical Trial.

5

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Jassoy C, Harrer T, Rosenthal T, Navia BA, Worth J, Johnson RP, Walker BD. Jassoy C, et al. J Virol. 1993 May;67(5):2844-52. doi: 10.1128/JVI.67.5.2844-2852.1993. J Virol. 1993. PMID: 7682629 Free PMC article.

6

Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.

Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD. Johnson RP, et al. J Virol. 1994 May;68(5):3145-53. doi: 10.1128/JVI.68.5.3145-3153.1994. J Virol. 1994. PMID: 7908700 Free PMC article.

7

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

Yang OO, Kalams SA, Rosenzweig M, Trocha A, Jones N, Koziel M, Walker BD, Johnson RP. Yang OO, et al. J Virol. 1996 Sep;70(9):5799-806. doi: 10.1128/JVI.70.9.5799-5806.1996. J Virol. 1996. PMID: 8709196 Free PMC article.

8

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.

Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'Aquila RT, Kurnick JT, Walker BD. Kalams SA, et al. J Exp Med. 1994 Apr 1;179(4):1261-71. doi: 10.1084/jem.179.4.1261. J Exp Med. 1994. PMID: 8145043 Free PMC article.

9

The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia.

Delgado JC, Leung JY, Baena A, Clavijo OP, Vittinghoff E, Buchbinder S, Wolinsky S, Addo M, Walker BD, Yunis EJ, Goldfeld AE. Delgado JC, et al. Immunogenetics. 2003 Oct;55(7):497-501. doi: 10.1007/s00251-003-0604-7. Epub 2003 Sep 27. Immunogenetics. 2003. PMID: 14517700

10

Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.

Cao H, Kanki P, Sankalé JL, Dieng-Sarr A, Mazzara GP, Kalams SA, Korber B, Mboup S, Walker BD. Cao H, et al. J Virol. 1997 Nov;71(11):8615-23. doi: 10.1128/JVI.71.11.8615-8623.1997. J Virol. 1997. PMID: 9343219 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year